Imperial Prostate

Salvage focal therapy for radiorecurrent prostate cancer has comparable 10-year cancer-specific survival to radical prostatectomy, but fewer complications in matched analyses Read our latest paper in @JAMAOnc! jamanetwork.com/journals/jamao… By @AJWLight @LondonProstate1 @TaimurShah

Focal prostate HIFU 🎯 What an honour, privilege & pleasure to now re-join the renowned Imperial Prostate team @IP_London team as Hons Consultant Urological Surgeon & deliver focal therapy! Very grateful to have been welcomed back warmly, and to help give best possible outcomes for our patients @ImperialSandC @ImperialNHS @FocalSociety @UkFocal @LondonProstate1 @TaimurShah

A study by researchers @AJWLight and @TaimurShah at the Trust and @imperialcollege has found that a targeted treatment called salvage focal therapy can effectively treat men whose prostate cancer returns after radiotherapy ➡️ imperial.nhs.uk/about-us/news/… #ProstateCancerAwarenessMonth

We are truly grateful for the great reception of our #FocalTherapy course at EAU2026. Beyond the strong attendance, the level of engagement and thoughtful discussion made it especially rewarding. @LondonProstate1 @Lara__Rodriguez @Uroweb @FocalSociety

@IP_London @AJWLight Very encouraging numbers, which will be really helpful for patient counseling. ADT-free survival isn’t often reported, so appreciate that finer point. Always amazed by the great work coming out of @IP_London

👏👏Well done to Alex Light, Urology Academic Trainee and NIHR doctoral fellow for a fantastic 7 abstracts this afternoon at #EAU26 #EAU2026 Progressing the field of focal therapy for prostate cancer. @AJWLight @IP_London @ImperialSandC @Uroweb @UkFocal @FocalSociety

And now moving to the radiorecurrent space... Which #MRI sequences add value for cancer detection after #Radiotherapy for #ProstateCancer? @AJWLight provides more data from the #FORECAST trial to finish up at #EAU26 - see you next year in #Amsterdam for #EAU27!

Can contrast-enhanced ultrasound #CEUS be used to evaluate completeness of ablation in #FocalTherapy for #ProstateCancer? @AJWLight presents the #ImperialProstate #FOCUS trial next at #EAU26

In the #AIM study, @AJWLight compares the diagnostic accuracy of the #TARGET and #PIFAB scores for reporting #MRI after #FocalTherapy with both showing outstanding negative predictive value #EAU26

#EAU guidelines suggest we could omit contralateral systematic biopsy in #ProstateCacner diagnostics - but what are the implications for #FocalTherapy treatment planning? @AJWLight sheds more light on this key question #EAU26

Continuing on the theme of #FocalTherapy; can we treat the index lesion without extending our ablation field to MR invisible areas of cancer? Early results suggest higher out of field recurrence rates @AJWLight #EAU26

Next, @AJWLight discusses his analysis of eligibility criteria proposed to select men for #FocalTherapy - how good are we at risk stratifying out patients and do we need better tools to individualise treatment decisions? #EAU26

Day 4 of #EAU26 belongs to our PhD student @AJWLight who presented 7 abstracts! Starting with some much needed 10-year focal therapy outcome data from the #HEAT and #ICE registries 🔥❄️

We are capping off four fantastic days at #EAU26 with @AJWLight presenting an incredible 7️⃣ abstracts! A remarkable finish to an outstanding weekend! 👏 @LondonProstate1 @ImperialSandC @ImperialNHS

Can primary tumour response dictate need to treat primary tumour in new mHSPC diagnoses? @Archana_GK1 - personalised treatment on the horizon possible from the internal pilot of #IP2ATLANTA, highlighting interesting changes response. Main trial results 2027 #EAU26 @Connor_Urol

The #IP6CHAIROS trial results reported by @LondonProstate1 #EAU26 Using the Ibex AI tool to detect GG2+ cancer on biopsy slides had sensitivity 97% and specificity 90% in this multicentre prospective blinded cohort study (n=597) Could we use this tool for biopsy slide triage?

Using data from #IP8FLUORESCE and #LaserSAFE, @NikhilMayor presents our development and validation of a deep learning tool for detecting positive margins during RARP using fluorescence confocal microscopy - highly accurate results! #EAU26

Another beautiful day in London and an exciting agenda for @IP_London at #EAU26 Day Three! ☀️ @LondonProstate1 @NikhilMayor @Archana_GK1

@LambAlastair @GuysUrology @MedResearchNSW @tsoburol @benchallacombe @Dr_Kamran_Haq @Cmartynhemphill @GSTTnhs @YoussefUrol @MattBultitude @prokarurol Not sure I agree with that premise. But look forward to seeing cooled laser focal therapy evaluated within a legally sponsored prospective REC/HRA/MHRA approved trial

#IP2ATLANTA pilot data being presented by @_Sam_Morris_ #EAU26 Local treatment (ablation > radical treatment) potentially improves urinary symptoms in de novo metastatic prostate cancer - the full study results are due Q1 2027

🎯 Packed room at focal therapy course #eau26 ‼️@LondonProstate1 draws a clear lesson from cardiothoracics … specialties that resist innovation can be left behind 👍BUT, effective FT needs proper training, thoughtful case selection & skilled delivery … led by urologists